Risk of cardiovascular involvement in pediatric patients with X-linked hypophosphatemia

Autor: Hernández-Frías O, Gil-Peña H, Pérez-Roldán JM, González-Sanchez S, Ariceta G, Chocrón S, Loza R, de la Cerda Ojeda F, Madariaga L, Vergara I, Fernández-Fernández M, Ferrando-Monleón S, Antón-Gamero M, Fernández-Maseda Á, Luis-Yanes MI, Santos F

Publikováno v: PEDIATRIC NEPHROLOGY
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)

Objective To find out if cardiovascular alterations are present in pediatric patients with X-linked hypophosphatemia (XLH). Study design Multicentre prospective clinical study on pediatric patients included in the RenalTube database (www.renaltube.co

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::43345a4230e3c3c1b94f22b9dd20445e
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=5743

Sildenafil restores cognitive function without affecting β-amyloid burden in a mouse model of Alzheimer's disease.

Autor: Cuadrado-Tejedor, M, Hervias, I, Ricobaraza, A, Puerta, E, Pérez-Roldán, JM, García-Barroso, C, Franco, R, Aguirre, N, García-Osta, A, Pérez-Roldán, J M, García-Barroso, C, García-Osta, A

Publikováno v: British Journal of Pharmacology; Dec2011, Vol. 164 Issue 8, p2029-2041, 13p

A case-control study of phosphodiesterase-5 inhibitor use and Alzheimer's disease and related dementias among male and female patients aged 65 years and older supporting the need for a phase III clinical trial.

Autor: Henry, David S.¹ (AUTHOR), Pellegrino, Richard G.¹ (AUTHOR) RGPellegrino@bhccr.com

Publikováno v: PLoS ONE. 10/18/2023, Vol. 18 Issue 10, p1-17. 17p.

Whole exome sequencing identifies two novel variants in PHEX and DMP1 in Malaysian children with hypophosphatemic rickets.

Autor: Tavana, Nahid¹ (AUTHOR), Ting, Tzer Hwu² (AUTHOR) tingth@upm.edu.my, Lai, Kaitao^3,4 (AUTHOR), Kennerson, Marina L.^3,5 (AUTHOR), Thilakavathy, Karuppiah^1,6 (AUTHOR) thilathy@upm.edu.my

Publikováno v: Italian Journal of Pediatrics. 12/8/2022, Vol. 48 Issue 1, p1-9. 9p.

An overview on pharmaceutical applications of phosphodiesterase enzyme 5 (PDE5) inhibitors.

Autor: Nemr MTM; Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Kasr El-Eini Street 11562, Cairo, Egypt. mohamed.nemr@pharma.cu.edu.eg., Abdelaziz MA; Department of Chemistry, College of Wooster, Wooster, OH, 44691, USA., Teleb M; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Alexandria University, Alexandria, 21521, Egypt.; Faculty of Pharmacy, Alamein International University (AIU), Alamein City, Alamein City, 5060310, Egypt., Elmasry AE; Organic & Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, Menoufia, Egypt., Elshaier YAAM; Organic & Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, Menoufia, Egypt. yaseen.elshaier@fop.usc.edu.eg.

Publikováno v: Molecular diversity [Mol Divers] 2024 Nov 27. Date of Electronic Publication: 2024 Nov 27.